Go to the target menu
Go to the pillar menu
Go to the search form
Go to the tools (print, share, increase, decrease font size)
Go to the left sidebar
Go to the content
Go to the right sidebar
Go to the tools menu

Our products - Giving new hope to patients with key therapeutic solutions

Tools content (print, share, increase/decrease text size):

Size
Share
Print

Our Products

Our websites

Sanofi worldwide

Middle area:

Consumer healthcare

Sanofi is a global leader in consumer healthcare.

Since 2008, with targeted acquisitions, Sanofi has been implementing an important strategy of diversifying. Accelerating growth in consumer healthcare also involves regional development hubs in the US, Europe, Asia-Pacific and Latin America.

The Consumer Healthcare portfolio of Sanofi includes world-renowned brand names that assure a strong presence in pain killers, digestive disorder remedies and treatments for coughs and colds. These include:

Doliprane®, Magné B6®, Enterogermina®, Essentiale®, Maalox®, No Spa® and Lactacyd®.

To continue the development of this activity, Sanofi has acquired the following companies:

Laboratoire Oenobiol in France.
Kernpharm in the Netherlands.
Chattem in the United States.
Nepentes S.A in Poland.
BMP Sunstone in China, who commercializes the leading brand of pediatric treatments for coughs and colds.
Candem Pharma in Canada.
Also, a joint venture agreement with the Chinese company Minsheng Pharmaceutical Co. Ltd has been completed.

Allegra®

Allegra® available over-the-counter for millions of allergic Americans.
Today, more than 40 million adult Americans suffer from allergies. In January 2011, the FDA approved the over-the-counter sale of the Allegra® (fexofenadine hydrochloride) range of allergy treatments.
Allegra® products are available in pharmacies, supermarkets and specialty shops at the start of the springtime allergy season.